{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_interleukin_17_inhibitors",
          "name": "Interleukin-17 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_topical_corticosteroids",
          "name": "Topical corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.81,
        "components": {
          "mechanism_fit": 0.85,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.75,
          "indication_plausibility": 0.8,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.01
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Acitretin 通过调节免疫反应同时影响皮肤炎症与损伤通路"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.78,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.55,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.75,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.02
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Apremilast 通过调节免疫反应来减轻皮肤和系统症状"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.84,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.02
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Etanercept 通过抑制免疫反应有效控制该病"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.84,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.02
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Infliximab 通过抑制免疫反应有效用于治疗"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.75,
        "components": {
          "mechanism_fit": 0.82,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.75,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.02
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Secukinumab 通过抑制免疫通路来减轻病症"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.72,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.45,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.65,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.03
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Cyclosporine 通过抑制免疫系统响应缓解病症"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.7,
        "components": {
          "mechanism_fit": 0.73,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.65,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.03
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Methotrexate 通过抑制免疫反应缓解病症"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.7,
        "components": {
          "mechanism_fit": 0.73,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.65,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.03
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Adalimumab 通过抑制免疫应答来缓解症状"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.72,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.65,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.03
        },
        "graph_signals": {
          "support_weight": 0.78,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Interleukin-17 inhibitors 通过抑制免疫通路减轻病症"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.68,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.03
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Topical corticosteroids 通过调节皮肤应答减轻炎症"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.69,
        "components": {
          "mechanism_fit": 0.72,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.03
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Ustekinumab 通过抑制免疫反应缓解病症"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.66,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.55,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.03
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Thalidomide 通过调节免疫反应可能有助于治疗"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H4",
      "H5",
      "H6",
      "H9",
      "H7",
      "H8",
      "H11",
      "H10",
      "H12"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_immune_response",
          "type": "Target",
          "label": "Immune Response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_psoriasis_pathway",
          "type": "Pathway",
          "label": "Psoriasis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised Pustular Psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pheno_skin_inflammation",
          "type": "Phenotype",
          "label": "Skin Inflammation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pheno_systemic_symptoms",
          "type": "Phenotype",
          "label": "Systemic Symptoms",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Acitretin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Apremilast",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Secukinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_interleukin_17_inhibitors",
          "type": "Drug",
          "label": "Interleukin-17 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_topical_corticosteroids",
          "type": "Drug",
          "label": "Topical corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Thalidomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_acitretin",
          "target": "n_target_immune_response",
          "relation": "modulates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于调节免疫反应"
        },
        {
          "source": "n_apremilast",
          "target": "n_target_immune_response",
          "relation": "modulates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于调节免疫反应"
        },
        {
          "source": "n_etanercept",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_infliximab",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_secukinumab",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_cyclosporine",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_methotrexate",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_adalimumab",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_interleukin_17_inhibitors",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_topical_corticosteroids",
          "target": "n_target_psoriasis_pathway",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知用于调节皮肤反应"
        },
        {
          "source": "n_ustekinumab",
          "target": "n_target_immune_response",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知用于抑制免疫反应"
        },
        {
          "source": "n_thalidomide",
          "target": "n_target_immune_response",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已知用于调节免疫反应"
        },
        {
          "source": "n_target_immune_response",
          "target": "n_target_psoriasis_pathway",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "调控通路关联"
        },
        {
          "source": "n_target_psoriasis_pathway",
          "target": "n_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "病理通路关联"
        },
        {
          "source": "n_target_immune_response",
          "target": "n_pheno_skin_inflammation",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "免疫反应引发皮肤炎症"
        },
        {
          "source": "n_target_immune_response",
          "target": "n_pheno_systemic_symptoms",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫反应引发系统性症状"
        }
      ],
      "round_index": 1
    },
    "history": {
      "round": 1
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "score": 0.81,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Acitretin 通过调节免疫反应减轻皮肤炎症",
          "对系统性症状的缓解有效"
        ],
        "caveats": [
          "需监测长期安全性"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "score": 0.78,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "Apremilast 能有效减轻皮肤和系统症状"
        ],
        "caveats": [],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "Etanercept 可抑制免疫反应，控制病情"
        ],
        "caveats": [],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H4_round2",
        "key_assumptions": [
          "Infliximab 在治疗中同样有效"
        ],
        "caveats": [],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "score": 0.75,
        "graph_snapshot_ref": "GE_H5_round2",
        "key_assumptions": [
          "Secukinumab 通过免疫通路的作用体现效果"
        ],
        "caveats": [],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H6",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "score": 0.72,
        "graph_snapshot_ref": "GE_H6_round2",
        "key_assumptions": [
          "Cyclosporine能够有效抑制症状"
        ],
        "caveats": [],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H9",
        "candidate": {
          "id": "drug_interleukin_17_inhibitors",
          "name": "Interleukin-17 inhibitors"
        },
        "score": 0.72,
        "graph_snapshot_ref": "GE_H9_round2",
        "key_assumptions": [
          "IL-17 抑制剂通过抑制免疫反应来减轻症状"
        ],
        "caveats": [],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H7",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "score": 0.7,
        "graph_snapshot_ref": "GE_H7_round2",
        "key_assumptions": [
          "Methotrexate 在免疫反应抑制中起到作用"
        ],
        "caveats": [],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H8",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "score": 0.7,
        "graph_snapshot_ref": "GE_H8_round2",
        "key_assumptions": [
          "Adalimumab 的作用逻辑跟其他生物制剂相似"
        ],
        "caveats": [],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H11",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "score": 0.69,
        "graph_snapshot_ref": "GE_H11_round2",
        "key_assumptions": [
          "Ustekinumab 在控症方面证据确切"
        ],
        "caveats": [],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H10",
        "candidate": {
          "id": "drug_topical_corticosteroids",
          "name": "Topical corticosteroids"
        },
        "score": 0.68,
        "graph_snapshot_ref": "GE_H10_round2",
        "key_assumptions": [
          "外用糖皮质激素能有效改善症状"
        ],
        "caveats": [],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H12",
        "candidate": {
          "id": "drug_thalidomide",
          "name": "Thalidomide"
        },
        "score": 0.66,
        "graph_snapshot_ref": "GE_H12_round2",
        "key_assumptions": [
          "Thalidomide 的治疗效果仍待验证"
        ],
        "caveats": [],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "多种药物通过不同途径调节免疫反应",
          "reason": "多个候选药物均显示出对病理通路的有效评估与干预"
        }
      ],
      "remaining_gaps": []
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "优先关注有效控制免疫反应之药物，监测长期疗效与安全性。"
      },
      {
        "role": "Skeptic",
        "patch": "强调对药物可能引起的长期副作用设立警示标识。"
      },
      {
        "role": "Explorer",
        "patch": "鼓励引入新型调节免疫机制药物，以扩展治疗选择。"
      }
    ],
    "heuristics": [
      {
        "when": "增加新进候选药物",
        "then": "确保其作用机制与现有药物有所不同，进行科学验证。"
      }
    ]
  }
}